
Clinical evaluation of potential usefulness of serum lactate dehydrogenase level in follow-up of small cell lung cancer
Author(s) -
Cheng Chen,
Ye-Han Zhu,
Jian-An Huang
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.168994
Subject(s) - lactate dehydrogenase , medicine , chemotherapy , gastroenterology , lung cancer , pathological , stage (stratigraphy) , receiver operating characteristic , oncology , cancer , pathology , biology , enzyme , paleontology , biochemistry
Lactate formation is upregulated in tumor cells by lactate dehydrogenase (LDH). High serum LDH level is linked to many malignancies with poorer survival, but tumor LDH has not been well investigated in small cell lung cancer (SCLC).